Results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s (AZN) Imfinzi in combination with standard-of-care FLOT chemotherapy demonstrated a statistically ...

Positive high-level results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s (AZN) Imfinzi in combination with standard-of-care FLOT chemotherapy ...

AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in early-stage stomach cancer met its main goal. When added to a ...

AstraZeneca is a company with a turbulent history ... But although it was dubbed a “dangerous game”, some companies came out on top... On 6th April 1999, two companies with similar science ...

A new study published in Cell Reports reveals a breakthrough discovery linking genetic variants in the gene ITSN1 to a significantly elevated risk of Parkinson's disease, a neurodegenerative condition ...

AstraZeneca and Honeywell are developing MDIs that will use a new propellant called HFO-1234ze, which, according to the company, has 99.9% less Global Warming Potential (GWP) than existing ...

WILMINGTON, Del. - AstraZeneca (AZN), a prominent player in the pharmaceuticals industry with a market capitalization of $239.77 billion, announced its IMFINZI (durvalumab) treatment has shown a ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

Customers include AstraZeneca, NASCAR, and The Economist. “What’s remarkable about Creatopy — especially for a relatively unknown company — is our ability to land major enterprise ...

The club, formerly known as Perry’s and Club 2K, has remained untouched since then - with its green Inside Out logo now damaged and surrounded by overgrown foliage. Opening in 2007 ...

More than 120 entries have been whittled down to the top 25 women aged under 40 tipped to spearhead the next generation of leading partners.